Chief Medical Officer

Spyre Therapeutics initiated with bullish view at Deutsche Bank, here's why

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases

Spyre Therapeutics announces first patient dosed in Phase 3 SKYWAY trial

Senior Medical Writer

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing innovative products for inflammatory bowel disease and other immune-mediated diseases. The Senior Medical Writer will be responsible for authoring and contributing to clinical and regulatory documents, ensuring high-quality submissions, and collaborating with cross-functional teams to meet project timelines.

Sign up with Google

Sign in with Google